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Vertebral fractures are twice as common as hip fractures in patients with
osteoporosis. Osteoporotic vertebral fracture (OVF) is dramatically
increasing in the ageing community. Over the last few years, there has been
considerable progress in understudying of bone biology and as a result
development of many new treatments. Recent progress in the research of
bone biology has enabled us to understand the molecular mechanisms
underlying bone metabolism. It was established that the differentiation of
osteoclasts, primary cells of bone resorption, is critically regulated by a TNF
family cytokine receptor activator of nuclear factor kappa B ligand (RANKL),
and a neutralizing antibody against RANKL (denosumab) markedly increases
bone mineral density and suppresses fragility fractures by suppressing bone
resorption. In addition, on the basis of the regulatory role of Wnt signaling in
bone formation, anti-sclerostin antibody has been developed as a powerful
bone anabolic agent. Treatment strategies based on the recent biological
findings will be covered. On the other hand, surgical treatments for OVFs are
indicated in many patients. If conservative treatments failed in those with
OVFs causing severe back pain, less invasive surgeries such as vertebroplasty
or balloon kyphoplasty are best indicated. Once neurological deficits
occurred due to progressive vertebral collapse or severe instability with
intravertebral clefts, neural decompression and spinal fusion with
instrumentation are required. There are many options available today to
treat OVFs according to the severity of kyphotic deformity, neurological
impairment and general conditions of each patient. Surgical treatment
should be customized in each patient to avoid both short-term and long-term
complications and to maintain better quality of life.i.org/10.1016/j.jot.2016.05.006SpeakersSpeaker 1: Current issue of osteoporotic vertebral fracture
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